|
SETD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.196900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.276440E-03 |
| Normal-vs-Stage2 |
1.864440E-01 |
| Normal-vs-Stage3 |
6.673700E-02 |
| Normal-vs-Stage4 |
7.403000E-01 |
| Stage1-vs-Stage2 |
7.738400E-01 |
| Stage1-vs-Stage3 |
8.370400E-01 |
| Stage1-vs-Stage4 |
1.866430E-01 |
| Stage2-vs-Stage3 |
9.362600E-01 |
| Stage2-vs-Stage4 |
4.317800E-01 |
| Stage3-vs-Stage4 |
3.165200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.375900E-04 |
| Normal-vs-AfricanAmerican |
2.216100E-03 |
| Normal-vs-Asian |
9.474400E-01 |
| Caucasian-vs-AfricanAmerican |
7.248600E-01 |
| Caucasian-vs-Asian |
2.575600E-01 |
| AfricanAmerican-vs-Asian |
2.024400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.001800E-04 |
| Normal-vs-Female |
7.277800E-03 |
| Male-vs-Female |
6.977000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.962100E-03 |
| Normal-vs-Extreme_Weight |
2.278600E-03 |
| Normal-vs-Obese |
1.304370E-03 |
| Normal-vs-Extreme_Obese |
5.094800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.953400E-01 |
| Normal_Weight-vs-Obese |
6.460800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.581570E-01 |
| Extreme_Weight-vs-Obese |
4.565600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.651400E-01 |
| Obese-vs-Extreme_Obese |
2.100400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.687790E-01 |
| Normal-vs-Age(41-60Yrs) |
2.238800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.338710E-03 |
| Normal-vs-Age(81-100Yrs) |
6.844000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.447800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.840600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.376000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.596000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.123500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.869640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.26610000001004E-06 |
| Normal-VS-Type2 PRCC |
5.100400E-01 |
| Normal-VS-KIRP CIMP |
2.867400E-01 |
| Normal-VS-Unclassified PRCC |
2.537600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.19380000000746E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.062900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.138800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.394200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.083800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.126300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.644270E-02 |
| Normal-vs-N1 |
2.076000E-01 |
| Normal-vs-N2 |
3.073600E-01 |
| N0-vs-N1 |
4.883200E-01 |
| N0-vs-N2 |
1.097980E-01 |
| N1-vs-N2 |
2.087800E-01 |
|
|
